It's not just chips. Nvidia is betting on other tech that could be impacted by AI. [Business Insider]
Recursion Pharmaceuticals, Inc. - Class A (RXRX)
Company Research
Source: Business Insider
Nvidia has invested in dozens of startups in 2023, including a company focused on pharmaceuticals. Nvidia, the California-based chip maker, is the latest tech company to so far have a blockbuster year as it surpassed expectations and flexed a market cap of more than $2 trillion by the end of February. That makes Nvidia one of the three largest companies by market cap, behind Microsoft and Apple. The company's recent boom can be explained by a fairly simple formula. Advancements in AI have fields beyond tech — like healthcare and finance — racing to figure out how to implement the technology. To do so, you need chips known as graphics processing units or GPUs that will power the AI tech. And Nvidia has the goods But chips aren't the only point of focus. Nvidia is looking elsewhere to take advantage of its current leverage in the recent AI craze. The company has been expanding its venture capital footprint and throwing money at startups applying AI to a wide range of indust
Show less
Read more
Impact Snapshot
Event Time:
RXRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RXRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RXRX alerts
High impacting Recursion Pharmaceuticals, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
RXRX
News
- Recursion Pharmaceuticals (RXRX) Declines More Than Market: Some Information for Investors [Yahoo! Finance]Yahoo! Finance
- Recursion Pharmaceuticals (RXRX) Dips More Than Broader Market: What You Should Know [Yahoo! Finance]Yahoo! Finance
- Where Will Recursion Pharmaceuticals Be in 5 Years? [Yahoo! Finance]Yahoo! Finance
- Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial OfficerGlobeNewswire
- Can Recursion Pharmaceuticals Stock Double in 5 Years? Here's What It Would Take. [Yahoo! Finance]Yahoo! Finance
RXRX
Earnings
- 2/27/24 - Beat
RXRX
Sec Filings
- 4/25/24 - Form 3
- 4/25/24 - Form 144
- 4/23/24 - Form ARS
- RXRX's page on the SEC website